Clofarabine
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 665 publications
Clinical Efficacy Analysis of 38 Pediatric Cases of Recurrent and Refractory Langerhans Cell Histiocytosis
Journal: Zhongguo shi yan xue ye xue za zhi
Published: January 08, 2026
Synthesis of Triphosphate Nucleoside Prodrugs: γ-ProTriPs.
Journal: Current protocols
Published: December 22, 2025
Phase I trial of the combination of bortezomib and clofarabine in adults with refractory tumors.
Journal: Cancer chemotherapy and pharmacology
Published: November 21, 2025
Interactive Use of Cox Model-Predicted Survival Curves: An Application Using ACS10 Score and Age to Personalize Treatment of Pediatric AML.
Journal: JCO precision oncology
Published: October 02, 2025
Clofarabine monotherapy in refractory multisystem LCH with gastrointestinal involvement.
Journal: Pediatric hematology and oncology
Published: September 24, 2025
Safety and efficacy of clofarabine for preconditioning intervention in patients undergoing allogeneic hematopoietic stem cell transplantation for relapsed/refractory acute lymphoblastic leukemia.
Journal: International journal of hematology
Published: September 19, 2025
Risk factors for alloimmune lung syndromes after allogeneic hematopoietic cell transplantation in children.
Journal: Bone marrow transplantation
Published: August 27, 2025
Epigenetic remodeling via HDAC6 inhibition amplifies anti-tumoral immune responses in myeloid leukemia cells.
Journal: Cell death & disease
Published: August 03, 2025
Discovery of a novel non-toxic analog of clofarabine for the treatment of triple-negative breast cancer.
Journal: Bioorganic & medicinal chemistry letters
Published: June 20, 2025
Exploring adenosine analogs for chondrosarcoma therapy: In vitro and in vivo insights.
Journal: Molecular therapy. Nucleic acids
Published: June 02, 2025
Last Updated: 04/28/2026